Sphingolipid Pathway as a Source of Vulnerability in IDH1<i><sup>mut</sup></i> Glioma.

Dowdy, Tyrone; Zhang, Lumin; Celiku, Orieta; Movva, Sriya; Lita, Adrian; Ruiz-Rodado, Victor; Gilbert, Mark R; Larion, Mioara

Sphingolipid Pathway as a Source of Vulnerability in IDH1^mut Glioma.

Dowdy, Tyrone; Zhang, Lumin; Celiku, Orieta; Movva, Sriya; Lita, Adrian; Ruiz-Rodado, Victor; Gilbert, Mark R; Larion, Mioara.

Afiliação

Dowdy T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Zhang L; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Celiku O; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Movva S; George Washington School of Medicine and Health Sciences, Washington, DC 20052, USA.
Lita A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Ruiz-Rodado V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Larion M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.

Cancers (Basel) ; 12(10)2020 Oct 10.

Article em En | MEDLINE | ID: mdl-33050528

Palavras-chave

IDHmut gliomas; N,N-dimethylsphingosine; sphinganine; sphingolipid metabolism; sphingosine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google